Opportunity
Federal Register #30Day-26-1406
CDC Seeks Comments on Data Collection for Traveler-based Genomic Surveillance Program
Buyer
Centers for Disease Control and Prevention
Posted
June 12, 2026
Identifier
30Day-26-1406
This notice concerns the Centers for Disease Control and Prevention (CDC) and its review of agency forms under the Paperwork Reduction Act, specifically for the Traveler-based Genomic Surveillance (TGS) program. - Government Buyer: - Department of Health and Human Services (HHS) - Centers for Disease Control and Prevention (CDC) - Program Focus: - Traveler-based Genomic Surveillance (TGS) program - Monitors communicable diseases among international air travelers at select U.S. airports - Data Collection Activities: - Use of participant questionnaires - Collection of nasal swab samples - Detection of pathogens such as SARS-CoV-2, Influenza A, and RSV - Purpose of Notice: - Seeks public and agency comments on the information collection process - Focuses on necessity, accuracy, and burden of data collection - No procurement of products or services is requested - No OEMs, vendors, or specific products are mentioned
Description
This notice announces that the Department of Health and Human Services, along with the Centers for Disease Control and Prevention, is reviewing certain agency forms under the Paperwork Reduction Act. The review process involves public comment and approval procedures. Specifically, the CDC has submitted the Traveler-based Genomic Surveillance (TGS) information collection request for review and approval, which involves monitoring communicable diseases among international air travelers. The program collects data via questionnaires and nasal swab samples to detect pathogens of public health importance.